Eton Pharmaceuticals Inc (ETON)
3.715
-0.04
(-0.93%)
USD |
NASDAQ |
May 07, 16:00
3.715
0.00 (0.00%)
After-Hours: 20:00
Eton Pharmaceuticals Shareholders Equity (Quarterly): 15.48M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.48M |
| September 30, 2023 | 16.89M |
| June 30, 2023 | 16.72M |
| March 31, 2023 | 11.24M |
| December 31, 2022 | 13.08M |
| September 30, 2022 | 11.18M |
| June 30, 2022 | 13.24M |
| March 31, 2022 | 13.38M |
| December 31, 2021 | 17.63M |
| September 30, 2021 | 15.66M |
| June 30, 2021 | 20.74M |
| March 31, 2021 | 21.56M |
| Date | Value |
|---|---|
| December 31, 2020 | 15.66M |
| September 30, 2020 | 1.388M |
| June 30, 2020 | 7.031M |
| March 31, 2020 | 10.62M |
| December 31, 2019 | 10.55M |
| September 30, 2019 | 12.35M |
| June 30, 2019 | 16.70M |
| March 31, 2019 | 19.24M |
| December 31, 2018 | 26.30M |
| September 30, 2018 | 4.751M |
| June 30, 2018 | 7.496M |
| March 31, 2018 | 10.16M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.388M
Minimum
Sep 2020
21.56M
Maximum
Mar 2021
13.74M
Average
13.38M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 12.81B |
| Evoke Pharma Inc | -2.580M |
| Outlook Therapeutics Inc | -24.34M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 31.74M |
| Total Liabilities (Quarterly) | 16.26M |
| Debt to Equity Ratio | 0.3476 |
| Current Ratio | 1.652 |
| Net Debt Paydown Yield | 0.18% |